Precious studies demonstrated that SSTR2 might serve as a molecular target in the diagnosis and treatment of thyroid cancer (Thakur et al., 2021), small intestinal neuroendocrine tumor (Elf et al., 2021), and neuroendocrine tumors (Si et al., 2021). Here, SSTR2 is linked to small intestine neuroendocrine neoplasm.